Bruker Debuts High-Fidelity Spatial Biology Platform and timsOmni Proteomics 2.0
At AGBT, Bruker unveiled a high-fidelity spatial biology platform to map biomolecules across tissue types for complete spatial omics analysis. It also rolled out its timsOmni Mass Spectrometry Proteoform Analysis, advancing functional proteomics 2.0 to dissect complex disease biology at the proteoform level.
1. Spatial Biology Platform Unveiling
At AGBT, Bruker introduced a high-fidelity spatial biology system engineered to capture biomolecular distributions across diverse tissue types, enabling researchers to perform comprehensive spatial omics studies with enhanced resolution and throughput.
2. timsOmni Proteoform Analysis Rollout
The new timsOmni Mass Spectrometry solution extends Bruker’s functional proteomics 2.0 suite by providing in-depth proteoform-level characterization, allowing precise identification of protein variants and post-translational modifications relevant to disease mechanisms.
3. Implications for Research and Market Expansion
These simultaneous launches expand Bruker’s life sciences portfolio, positioning the company to meet growing demand from academic, pharmaceutical and biotech labs for advanced spatial and proteomic analytical tools.